These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26899186)

  • 1. Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site.
    Wu X; Wang Q; Li W
    Anticancer Agents Med Chem; 2016; 16(10):1325-38. PubMed ID: 26899186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site.
    Li L; Jiang S; Li X; Liu Y; Su J; Chen J
    Eur J Med Chem; 2018 May; 151():482-494. PubMed ID: 29649743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures.
    Li W; Sun H; Xu S; Zhu Z; Xu J
    Future Med Chem; 2017 Oct; 9(15):1765-1794. PubMed ID: 28929799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the recent advances and discovery of novel tubulin colchicine binding inhibitors.
    Weng H; Li J; Zhu H; Carver Wong KF; Zhu Z; Xu J
    Future Med Chem; 2023 Jan; 15(1):73-95. PubMed ID: 36756851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery.
    Wang Y; Zhang H; Gigant B; Yu Y; Wu Y; Chen X; Lai Q; Yang Z; Chen Q; Yang J
    FEBS J; 2016 Jan; 283(1):102-11. PubMed ID: 26462166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody- Drug Conjugates and Degradation Agents.
    Duan Y; Liu W; Tian L; Mao Y; Song C
    Curr Top Med Chem; 2019; 19(15):1289-1304. PubMed ID: 31210108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of tubulin inhibitors that interact with the colchicine binding site.
    Lu Y; Chen J; Xiao M; Li W; Miller DD
    Pharm Res; 2012 Nov; 29(11):2943-71. PubMed ID: 22814904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin.
    Sun K; Sun Z; Zhao F; Shan G; Meng Q
    Future Med Chem; 2021 May; 13(9):839-858. PubMed ID: 33821673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butterfly Structure: A Privileged Scaffold Targeting Tubulin-Colchicine Binding Site.
    Wang Y; Yao Y; Zhu HL; Duan Y
    Curr Top Med Chem; 2020; 20(17):1505-1508. PubMed ID: 32543362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.
    Yang J; Yan W; Yu Y; Wang Y; Yang T; Xue L; Yuan X; Long C; Liu Z; Chen X; Hu M; Zheng L; Qiu Q; Pei H; Li D; Wang F; Bai P; Wen J; Ye H; Chen L
    J Biol Chem; 2018 Jun; 293(24):9461-9472. PubMed ID: 29691282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective.
    Wang J; Miller DD; Li W
    Drug Discov Today; 2022 Mar; 27(3):759-776. PubMed ID: 34890803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and biological evaluation of 4,6-pyrimidine analogues with potential anticancer agents as novel colchicine binding site inhibitors.
    Zhang J; Tan L; Wu C; Li Y; Chen H; Liu Y; Wang Y
    Eur J Med Chem; 2023 Feb; 248():115085. PubMed ID: 36621138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy.
    Hawash M
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
    Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
    Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
    Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
    Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydropathic analysis and biological evaluation of stilbene derivatives as colchicine site microtubule inhibitors with anti-leukemic activity.
    Tripathi A; Durrant D; Lee RM; Baruchello R; Romagnoli R; Simoni D; Kellogg GE
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1237-44. PubMed ID: 19912057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.
    Sun M; Yuan M; Kang Y; Qin J; Zhang Y; Duan Y; Wang L; Yao Y
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):339-354. PubMed ID: 34979843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Modification of the 3,4,5-Trimethoxyphenyl Moiety in the Tubulin Inhibitor VERU-111 Leads to Improved Antiproliferative Activities.
    Wang Q; Arnst KE; Wang Y; Kumar G; Ma D; Chen H; Wu Z; Yang J; White SW; Miller DD; Li W
    J Med Chem; 2018 Sep; 61(17):7877-7891. PubMed ID: 30122035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site.
    Dong M; Liu F; Zhou H; Zhai S; Yan B
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27754459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel 5-(4-chlorophenyl)furan derivatives with inhibitory activity on tubulin polymerization.
    Moussa SA; A Osman EE; Eid NM; Abou-Seri SM; El Moghazy SM
    Future Med Chem; 2018 Aug; 10(16):1907-1924. PubMed ID: 29966433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.